Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry

SNUH dexamethasone/hyaluronic-acid intratympanic delivery study

Also known as: Dexamethasone plus hyaluronic acid delivery vehicle, NCT04766853

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Therapeutic

Modality

Drug Delivery

Stage

Phase 1/2

Status

Completed

Target Gene

—

Route / Mode

Intratympanic injection

Confidence

76%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

South Korea

Population

adult, sudden, sensorineural, drug-delivery, study-level

Trial IDs

Mechanism

Completed randomized Phase 1/2 pilot comparing intratympanic dexamethasone plus saline with dexamethasone plus hyaluronic acid as a delivery vehicle for intractable hearing-loss conditions.

Indications

Hearing Loss Sensorineural Hearing Loss Sudden Sensorineural Hearing Loss Cisplatin-Induced Hearing Loss Noise-Induced Hearing Loss Meniere Disease

Notes

Split out from the broad dexamethasone cluster. ClinicalTrials.gov verifies a completed Seoul National University Hospital intratympanic drug-delivery pilot; this is a study-level delivery-vehicle record, not a proprietary dexamethasone product.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, aliases, company, allCompanies, isIndustrySponsored, programType, modality, mechanism...

IDs: NCT04766853

Open

Key Events

2021-07-22

Registry-listed actual start of SNUH intratympanic dexamethasone/hyaluronic-acid delivery study

2024-07-19

Registry-listed actual completion of SNUH delivery study

Clinical Trials (1)